Loading companies…
C
Chemify
United Kingdom · Industrial tech · Biotech
Chemify turns digital chemistry programs into real molecules through software, robotics and AI. Pharmaceutical, biotechnology and materials R&D teams can use its Chemputation platform and automated Chemifarm to design, synthesize and test compounds.
A program that makes molecules
Chemify’s Chemputation system combines a chemical programming language with software, AI and robotics to turn digital instructions into physical molecules. Researchers can use it to design and execute chemical synthesis, linking computational planning with laboratory experiments rather than stopping at a predicted structure.
Automated synthesis for R&D teams
The company serves pharmaceutical, biotechnology and industrial partners working on medicines and materials. Its first Chemifarm opened in Glasgow in 2025, bringing molecule design and robotic synthesis together in one facility. The system is operating as a research and synthesis platform, while Chemify’s longer-term ambition is to make a much broader range of chemical design and production programmable and available on demand.
- Headquarters
- Scotland, United Kingdom
- Facility
- Chemifarm, Glasgow
- Team
- 200+ employees
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| £22 million grant package | £22M | Scottish Enterprise — ParticipantUK Government — Participant |
Investors
Scottish EnterpriseJoined £22 million grant packageUK GovernmentJoined £22 million grant packageCoverage
Sep 16, 2026Chemify · £22 million grant packageSimilar companies
ACAdvance Composite Co., Ltd.An advanced-materials manufacturer combining metals with ceramics or graphite for thermal and precision-engineering applications.Undisclosed · Series B
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
AventixAventix builds sensor-based analytical instruments for laboratories. Its first product, Scarlett 01, measures liquid volumes across microplate wells without touching the sample, helping R&D teams check dispensing quality and catch volume variation before it affects assay results.€1.2M · Pre-seed